Streptococcus pneumoniae |
Primary cause in adults, associated with pneumonia, sinusitis, and otitis media. Higher incidence in alcoholics, diabetics, post-splenectomy, complement deficiency, basal skull fractures, and CSF rhinorrhoea. |
Penicillin G if sensitive; Ceftriaxone (2g IV BD) or Cefotaxime (2g IV QID) initially, with Vancomycin (15-20 mg/kg) added if resistance is suspected. 2-week course. |
Neisseria meningitidis |
Main cause in children and adolescents; petechial rash is common. Risk increased with complement deficiencies. |
Penicillin G if sensitive; Ceftriaxone (2g IV BD) or Cefotaxime (2g IV QID). |
Haemophilus influenzae |
Reduced incidence due to vaccination. |
Cefotaxime (2g IV QID) or Ceftriaxone (2g IV BD). |
Gram-negative bacteria |
Common in diabetics, cirrhotics, or post-craniotomy patients. |
Cefotaxime (2g IV QID) or Ceftriaxone (2g IV BD) for 3 weeks. |
Group B streptococci |
Traditionally a neonatal infection, now seen across all ages. |
Penicillin G (3 million units IV every 4 hours) or Ampicillin (2g IV every 4 hours). |
Listeria monocytogenes |
Common in neonates, pregnant women, immunocompromised, and older adults; often foodborne. |
Ampicillin (2g IV every 4 hours) for 3 weeks, sometimes with Gentamicin (5 mg/kg IV daily, divided over 3 doses). |
Staphylococcus aureus |
Typically follows neurosurgical intervention or certain underlying conditions. |
Vancomycin (15-20 mg/kg IV every 12 hours) is preferred. |
Cryptococcus neoformans |
Common in immunocompromised individuals. |
Amphotericin B (0.7 mg/kg IV daily) plus flucytosine (100 mg/kg divided into four doses) for 2 weeks, followed by fluconazole (400 mg daily) for maintenance. |